Electronic prescribing controlled substance policy epcs

Ended Awarded Last action

Contract number
75FCMC22F0002
Awardee
Awarding agency
Obligated
$2,059,277

Award facts

Contract value 92% obligated
$2,232,426.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
West McLean, VA 22102, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 · EOI::defend the spend (february 6, 2025)::EOI modification to descope non-essential consulting services -$173,149
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope P00003 $444,996
Exercise an Option P00002 $374,261
Exercise an Option P00001 $913,392
Original award $499,777

About this award

The Centers for Medicare and Medicaid Services awarded a $2.23M delivery order to The Mitre Corporation under the CMS Alliance to Modernize Healthcare (HEALTH) Federally Funded Research and Development Center (FFRDC) Indefinite Delivery/Indefinite Quantity contract. This delivery order, issued on May 18, 2022, with an ultimate completion date of June 15, 2025, addresses Electronic Prescribing of Controlled Substances (EPCS) policy initiatives. The contract utilizes a Cost Plus Fixed Fee pricing structure and does not carry a set-aside designation. Work will be performed in West McLean, Virginia. This delivery order was subject to a modification in February 2025 to descope non-essential consulting services under the "Defend the Spend" initiative, reflecting efforts to optimize federal spending.

As a leading non-profit FFRDC, Mitre provides comprehensive scientific, technical, and acquisition support services across multiple government domains, with particular expertise in systems engineering, information technology, cybersecurity, and enterprise modernization. The $2B parent HEALTH FFRDC contract enables CMS to modernize healthcare programs through strategic advisory services, data analytics, and technical research support. This EPCS delivery order contributes to the modernization and optimization of controlled substance prescribing processes within the federal healthcare system, aligning with CMS's broader digital transformation and healthcare program improvement objectives.

Quick answers

Who was awarded contract 75FCMC22F0002?

75FCMC22F0002 was awarded to The Mitre Corporation by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on May 18, 2022.

How much is contract 75FCMC22F0002 worth?

The government has obligated $2,059,277 on 75FCMC22F0002. Its current value, with exercised options, is $2,232,426.

Is contract 75FCMC22F0002 an order under another contract?

Yes. 75FCMC22F0002 is a delivery order under 75FCMC18D0047, an indefinite delivery contract.

Was contract 75FCMC22F0002 competed?

The extent of competition for 75FCMC22F0002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award